Paul J. Wyckoff
On January 6, 2025, Paul J. Wyckoff was appointed Cemtrex’s Chief Financial Officer
Highest-materiality recent filing
Cemtrex announces 1-for-15 reverse stock split effective June 5, 2026 to regain Nasdaq compliance
1-for-15 reverse split effective June 5, 2026 at 12:01 a.m. ET; symbol CETX unchanged; new CUSIP 15130G865.
Cemtrex shareholders elect four directors and ratify Grassi as auditor at annual meeting
All four nominees (Saagar Govil, Brian Kwon, Manpreet Singh, Mitodi Filipov) elected with >102.7M votes each.
Cemtrex acquires Invocon for $7.06M cash; Invocon FY2024 net loss $310K
Cemtrex completed Invocon acquisition on Jan 8, 2026 for $7.06M cash, funded from existing cash.
Cemtrex to pay Series 1 Preferred Stock dividend in additional shares, not cash
Board resolved to pay semiannual 10% dividend on Series 1 Preferred Stock in additional shares.
Asset and facility purchase price $5.5M ($600K business + $4.9M real estate), financed via Fulton Bank loans.
Cemtrex raises $4M in registered direct offering of common stock and pre-funded warrants
Issued 400,000 shares and pre-funded warrants for 1,069,507 shares at $2.722/share to single institutional investor.
Cemtrex completes $7.06M cash acquisition of Invocon, launches Aerospace & Defense segment
Acquired 100% of Invocon for $7,060,000 cash; transaction closed January 8, 2026.
Cemtrex raises $2M in registered direct offering of common stock and warrants
Gross proceeds of $2.0M from sale of 340,000 common shares and pre-funded warrants for 548,889 shares at $2.25 per share-equivalent.
Cemtrex raises $2M in registered direct offering of common stock and pre-funded warrants
Issued 330,000 shares of common stock and pre-funded warrants for 470,000 shares at $2.50 each.
Cemtrex issues 4.76M shares to settle $6.1M debt and raise $5.5M via warrants
Issued 2,500,609 shares on Dec 8, 2025 to satisfy $6,084,000 of debt under exchange agreements.
Cemtrex closes $2M registered direct offering of common stock and pre-funded warrants
Issued 310,000 common shares and pre-funded warrants for 356,667 shares at $3/share.
Cemtrex agrees to acquire aerospace/defense firm Invocon for $7.06M
Purchase of 100% of Invocon for $7,060,000 in cash; net working capital adjustment with target NWC ≥ $500K.
Cemtrex issues $7.025M promissory note to Streeterville Capital; proceeds for acquisitions
Note of $7,025,000 issued to Streeterville Capital; net cash of $7,000,000 after $25k origination fee.
Cemtrex announces 1-for-15 reverse stock split to regain Nasdaq compliance
Reverse split at 1-for-15 effective September 29, 2025; symbol CETX unchanged.
Cemtrex to pay 10% Series 1 Preferred dividend in additional preferred shares
Dividend rate 10% annually on $10.00 per share Preference Amount, payable semiannually.
Cemtrex regains Nasdaq compliance with $6.4M stockholders' equity
Nasdaq confirmed June 4, 2025 that Cemtrex meets minimum stockholders' equity requirement.
Cemtrex closes underwriter over-allotment option for 187,500 shares at $1.00, gross $187,500
Over-allotment option fully exercised June 2, shares sold on June 3, 2025.
Cemtrex closes over-allotment in public offering, raising ~$187,500 from 187,500 shares at $1.00
Underwriter fully exercised 45-day option for 187,500 shares at $1.00/share on June 2.
Cemtrex closes $1.25M public offering of 1.25M shares at $1.00/share
Offering of 1,250,000 shares at $1.00 per share for gross proceeds of $1.25 million.
Cemtrex shareholders elect four directors and ratify auditor at annual meeting
Elected Saagar Govil, Brian Kwon, Manpreet Singh, and Mitodi Filipov to the board with ~19.9M–20.3M votes each.
Cemtrex gets Nasdaq extension to Aug 20, 2025 to regain minimum equity compliance
Nasdaq granted extension until Aug 20, 2025 to meet minimum $2.5M stockholders' equity requirement.
Cemtrex to pay Series 1 Preferred dividend in stock on April 7, 2025
Board resolved to pay Series 1 Preferred dividend in additional shares rather than cash.
Cemtrex receives Nasdaq delisting notice for stockholders' equity below $2.5M
Stockholders' equity of $(1.56M) as of Dec 31, 2024, below Nasdaq's $2.5M minimum.
Cemtrex regains Nasdaq listing compliance with $4.71M equity
Received Nasdaq notice on Jan 2, 2025 confirming compliance with minimum stockholders' equity requirement.
Cemtrex appoints Paul J. Wyckoff as Chief Financial Officer effective Jan 6, 2025
Paul J. Wyckoff appointed CFO, overseeing financial planning, accounting, tax, and business process functions.
Cemtrex regains Nasdaq minimum bid price compliance
Received Nasdaq notice on Dec 11, 2024 confirming regained compliance with minimum bid price rule.
Cemtrex reports share count and warrant details after 1-for-35 reverse stock split
Reverse stock split effective after close on November 25, 2024.
Cemtrex approves 1-for-35 reverse stock split effective Nov 26 to regain Nasdaq compliance
Reverse split ratio of 1-for-35; effective at 12:01 a.m. ET on November 26, 2024; CUSIP changes to 15130G881.
Cemtrex gets Nasdaq extension to Feb 17, 2025 to cure equity deficiency
Nasdaq granted extension for minimum $2.5M stockholders' equity compliance.
Cemtrex provides post-split share count as of Oct 15, 2024: 25.6M shares outstanding
One-for-sixty reverse stock split effective Oct 3, 2024; warrants exercised post-split.
Cemtrex announces 1-for-60 reverse stock split to regain Nasdaq compliance
Reverse stock split at 1-for-60 ratio effective Oct 3, 2024 at 12:01 a.m. ET.
Cemtrex to pay Series 1 Preferred stock dividend in additional shares
Board resolved to pay 10% annual dividend on Series 1 Preferred in additional shares instead of cash.
Stockholders' equity of $47,956 on June 30, 2024 is well below Nasdaq's $2.5M minimum requirement.
Cemtrex increases authorized common shares from 50M to 70M via charter amendment
Board and majority stockholders approved amendment to increase authorized common shares from 50,000,000 to 70,000,000.
Cemtrex receives Nasdaq delisting notice for bid price below $1.00 for 30 days
Received Nasdaq deficiency letter on June 14, 2024; bid price below $1.00 for 30 consecutive trading days.
Cemtrex shareholders elect four directors and ratify auditor at 2024 annual meeting
All four director nominees (Saagar Govil, Brian Kwon, Manpreet Singh, Mitodi Filipov) elected with >12M votes each.
Cemtrex closes public offering of units, raising ~$10.0M gross proceeds
Aggregate gross proceeds to company ~$10.0M from sale of 11,764,705 Units and 11,210,000 Pre-Funded Units.
Cemtrex signs standstill with Streeterville; must pay 50% of equity proceeds or $4M
Streeterville agrees to one-year redemption standstill on two notes ($5.755M Sep-2021 and $9.205M Feb-2022) conditional on at least $9M financing by May 10, 2024.
Cemtrex to pay 10% annual PIK dividend on Series 1 Preferred Stock
Board resolved to pay dividend on Series 1 Preferred Stock in additional shares rather than cash.
On January 6, 2025, Paul J. Wyckoff was appointed Cemtrex’s Chief Financial Officer
Max materiality 0.85 · Median 0.60 · Most common event other_material